- Filed
- Mar 31, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2025 · Mar 27, 2026 | 4.16M sh |
| Shares Diluted | FY 2025 · Dec 31, 2025 | 3.32M sh |
| Shares Diluted restated | FY 2025 · Dec 31, 2024 | 2.93M sh |
| Capex | FY 2025 · Dec 31, 2025 | $64.44K |
| Operating Cash Flow | FY 2025 · Dec 31, 2025 | −$12.33M |
| Operating Cash Flow | FY 2025 · Dec 31, 2024 | −$12M |
| Cash And Equivalents | FY 2025 · Dec 31, 2025 | $0 |
| Cash And Equivalents | FY 2025 · Dec 31, 2024 | $0 |
| Stockholders Equity | FY 2025 · Dec 31, 2025 | −$8.23M |
| Stockholders Equity | FY 2025 · Dec 31, 2024 | −$6.67M |
| Stockholders Equity restated | FY 2025 · Dec 31, 2023 | −$94.43M |
| Current Liabilities | FY 2025 · Dec 31, 2025 | $7.07M |
| Current Liabilities | FY 2025 · Dec 31, 2024 | $9.04M |
| Total Liabilities | FY 2025 · Dec 31, 2025 | $12.62M |
| Total Liabilities | FY 2025 · Dec 31, 2024 | $10.14M |
| Current Assets | FY 2025 · Dec 31, 2025 | $1.54M |
| Current Assets | FY 2025 · Dec 31, 2024 | $2.36M |
| Total Assets | FY 2025 · Dec 31, 2025 | $4.38M |
| Total Assets | FY 2025 · Dec 31, 2024 | $3.46M |
| Eps Diluted | FY 2025 · Dec 31, 2025 | −$8.08 |
| Eps Diluted restated | FY 2025 · Dec 31, 2024 | −$3.50 |
| Eps Basic | FY 2025 · Dec 31, 2025 | −$8.08 |
| Eps Basic restated | FY 2025 · Dec 31, 2024 | −$3.50 |
| Sga Expense | FY 2025 · Dec 31, 2025 | $15.03M |
| Sga Expense | FY 2025 · Dec 31, 2024 | $22.53M |
| Rd Expense | FY 2025 · Dec 31, 2025 | $11.11M |
| Rd Expense | FY 2025 · Dec 31, 2024 | $31.03M |
| Net Income | FY 2025 · Dec 31, 2025 | −$26.28M |
| Net Income | FY 2025 · Dec 31, 2024 | −$13.73M |
| Operating Income | FY 2025 · Dec 31, 2025 | −$26.14M |
| Operating Income | FY 2025 · Dec 31, 2024 | −$53.56M |